{
  "trial_id": "NCT02258074",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, estimated glomerular filtration rate (eGFR), serum phosphate, platelet count, liver function tests (AST, ALT, alkaline phosphatase, total bilirubin), creatine kinase (CK) concentrations, history of major hemorrhagic events, history of blood or platelet transfusion, parathyroid hormone (PTH) levels, hemoglobin (Hg) levels, serum albumin, use of immunosuppressive medications, alcohol or drug abuse status, use of vitamin D or analogues, use of phosphate binders or niacin/nicotinamide, participation in other clinical trials, use of investigational drugs, institutionalization status, history of malignancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "eGFR",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Serum Phosphate",
          "serum phosphate"
        ],
        [
          "Intact PTH",
          "parathyroid hormone (PTH) levels"
        ],
        [
          "Serum Calcium",
          "serum albumin"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Diabetes Mellitus",
        "Systolic BP",
        "Diastolic BP",
        "Body Mass Index",
        "Urine Albumin Creatinine Ratio",
        "Calcitriol Use",
        "Serum FGF-23",
        "Urine Phosphorus",
        "Phosphorus/Creatinine Ratio"
      ],
      "remaining_candidate_features": [
        "platelet count",
        "liver function tests (AST, ALT, alkaline phosphatase, total bilirubin)",
        "creatine kinase (CK) concentrations",
        "history of major hemorrhagic events",
        "history of blood or platelet transfusion",
        "hemoglobin (Hg) levels",
        "use of immunosuppressive medications",
        "alcohol or drug abuse status",
        "use of vitamin D or analogues",
        "use of phosphate binders or niacin/nicotinamide",
        "participation in other clinical trials",
        "use of investigational drugs",
        "institutionalization status",
        "history of malignancy"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Estimated Glomerular Filtration Rate (eGFR), Serum Phosphate, Platelet Count, Serum Albumin, Hemoglobin, Parathyroid Hormone (PTH), Use of Vitamin D or Analogues,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "eGFR",
          "Estimated Glomerular Filtration Rate (eGFR)"
        ],
        [
          "Serum Phosphate",
          "Serum Phosphate"
        ],
        [
          "Serum Albumin",
          "Serum Albumin"
        ],
        [
          "Intact PTH",
          "Parathyroid Hormone (PTH)"
        ],
        [
          "Calcitriol Use",
          "Use of Vitamin D or Analogues"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Diabetes Mellitus",
        "Systolic BP",
        "Diastolic BP",
        "Body Mass Index",
        "Urine Albumin Creatinine Ratio",
        "Serum FGF-23",
        "Serum Calcium",
        "Urine Phosphorus",
        "Phosphorus/Creatinine Ratio"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Platelet Count",
        "Hemoglobin"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, eGFR, Serum Phosphate, Platelet Count, History of Allergic Reaction, Liver Disease, Creatine Kinase Concentrations, History of Major Hemorrhagic Event, Blood or Platelet Transfusion, Secondary Hyperparathyroidism, Anemia, Serum Albumin, Anticipated Initiation of Dialysis or Kidney Transplantation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "eGFR",
          "eGFR"
        ],
        [
          "Serum Phosphate",
          "Serum Phosphate"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Diabetes Mellitus",
        "Systolic BP",
        "Diastolic BP",
        "Body Mass Index",
        "Urine Albumin Creatinine Ratio",
        "Calcitriol Use",
        "Serum FGF-23",
        "Serum Calcium",
        "Intact PTH",
        "Urine Phosphorus",
        "Phosphorus/Creatinine Ratio"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Platelet Count",
        "History of Allergic Reaction",
        "Liver Disease",
        "Creatine Kinase Concentrations",
        "History of Major Hemorrhagic Event",
        "Blood or Platelet Transfusion",
        "Secondary Hyperparathyroidism",
        "Anemia",
        "Serum Albumin",
        "Anticipated Initiation of Dialysis or Kidney Transplantation."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, eGFR, serum phosphate, platelet count, creatine kinase concentrations, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, total bilirubin concentrations, parathyroid hormone (PTH) levels, serum albumin, hemoglobin, body mass index (BMI), medical history (including liver disease, kidney disease, and malignancy), medication use (including immunosuppressive medications, vitamin D analogues, phosphate binders, and niacin/nicotinamide).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "eGFR",
          "eGFR"
        ],
        [
          "Serum Phosphate",
          "serum phosphate"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Intact PTH",
          "parathyroid hormone (PTH) levels"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Diabetes Mellitus",
        "Systolic BP",
        "Diastolic BP",
        "Urine Albumin Creatinine Ratio",
        "Calcitriol Use",
        "Serum FGF-23",
        "Serum Calcium",
        "Urine Phosphorus",
        "Phosphorus/Creatinine Ratio"
      ],
      "remaining_candidate_features": [
        "platelet count",
        "creatine kinase concentrations",
        "aspartate aminotransferase (AST)",
        "alanine aminotransferase (ALT)",
        "alkaline phosphatase",
        "total bilirubin concentrations",
        "serum albumin",
        "hemoglobin",
        "medical history (including liver disease, kidney disease, and malignancy)",
        "medication use (including immunosuppressive medications, vitamin D analogues, phosphate binders, and niacin/nicotinamide)"
      ]
    }
  }
}